It promotes colorectal cancer progression by enhancing the interaction between BRAF and Mitogen-activated protein kinase kinase 1 (MEK1), leading to the activation of the mitogen-activated protein kinase (MAPK) signaling pathway [120]. The gene discussed is MAP2K1; the disease is colorectal cancer.